Efficacy of vemurafenib, a selective BRAFV600E inhibitor, in combination with a MEK inhibitor in BRAFV600E colorectal cancer models.

被引：1
|
作者：
Higgins, Brian
Kolinsky, Kenneth Daniel
Yang, Hong
Kim, Min Jung
Li, Jia Kui
Go, Zenaida
Packman, Kathryn
Bollag, Gideon
Su, Fei
机构：
[1] Hoffmann Roche Inc, Pharma Res & Early Dev, Nutley, NJ USA
[2] Plexxikon Inc, Berkeley, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.488
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
488
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BRAFv600E INHIBITOR(VEMURAFENIB) IN PEDIATRIC PATIENTS AFFECTED BY BRAFv600E MUTATED GLIOMAS
    del Bufalo, Francesca
    Cacchione, Antonella
    Carai, Andrea
    Antonelli, Manila
    Giangaspero, Felice
    Ferretti, Elisabetta
    Catanzaro, Giuseppina
    Miele, Evelina
    Badiali, Manuela
    Pettorini, Benedetta
    Mastronuzzi, Angela
    [J]. NEURO-ONCOLOGY, 2016, 18 : 24 - 24
  • [2] Preclinical combinations of vemurafenib, a selective BRAF inhibitor, with other targeted therapies in BRAFV600E colorectal cancer models
    Yang, Hong
    Higgins, Brian
    Kolinsky, Kenneth
    Li, Jiakui
    Margolis, Richard
    Go, Zenaida
    Railkar, Aruna
    Packman, Kathryn
    Bollag, Gideon
    Su, Fei
    [J]. CANCER RESEARCH, 2012, 72
  • [3] The BRAFV600E kinase inhibitor vemurafenib induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E mutated melanoma cells
    Beck, D.
    Niessner, H.
    Flaherty, K.
    Vasseur, S.
    Iovanna, J. L.
    Bauer, J.
    Weide, B.
    Kulms, D.
    Schadendorf, D.
    Garbe, C.
    Meier, F.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (09): : 792 - 792
  • [4] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    J S Wilmott
    A M Menzies
    L E Haydu
    D Capper
    M Preusser
    Y E Zhang
    J F Thompson
    R F Kefford
    A von Deimling
    R A Scolyer
    G V Long
    [J]. British Journal of Cancer, 2013, 108 : 924 - 931
  • [5] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    Wilmott, J. S.
    Menzies, A. M.
    Haydu, L. E.
    Capper, D.
    Preusser, M.
    Zhang, Y. E.
    Thompson, J. F.
    Kefford, R. F.
    von Deimling, A.
    Scolyer, R. A.
    Long, G. V.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 924 - 931
  • [6] COMBINED BRAFV600E AND MEK INHIBITION FOR BRAFV600E-MUTANT ASTROCYTOMAS
    Zhang, Jie
    Hariono, Sujatmi
    Yao, Tsun-Wen
    Sidhu, Angadpreet
    Hashizume, Rintaro
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore P.
    [J]. NEURO-ONCOLOGY, 2013, 15 : 60 - 61
  • [7] Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
    Zhang, Jie
    Yao, Tsun-Wen
    Hashizume, Rintaro
    Hariono, Sujatmi
    Barkovich, Krister J.
    Fan, Qi-Wen
    Prados, Michael
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (03) : 495 - 505
  • [8] Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas
    Jie Zhang
    Tsun-Wen Yao
    Rintaro Hashizume
    Sujatmi Hariono
    Krister J. Barkovich
    Qi-Wen Fan
    Michael Prados
    C. David James
    William A. Weiss
    Theodore Nicolaides
    [J]. Journal of Neuro-Oncology, 2017, 131 : 495 - 505
  • [9] A SAFETY STUDY OF VEMURAFENIB, AN ORAL INHIBITOR OF BRAFV600E, IN CHILDREN WITH RECURRENT/REFRACTORY BRAFV600E MUTANT BRAIN TUMORS: PNOC-002
    Nicolaides, Theo
    Nazemi, Kellie
    Crawford, John
    Kilburn, Lindsay
    Minturn, Jane
    Gajjar, Amar
    Gauvain, Karen
    Leary, Sarah
    Dhall, Girish
    Aboian, Mariam
    Robinson, Giles
    Molinaro, Annette
    Mueller, Sabine
    Prados, Michael
    [J]. NEURO-ONCOLOGY, 2017, 19 : 188 - 188
  • [10] BRAFV600E Inhibitor Radiosensitizes Thyroid Cancer-Letter
    Gottgens, Eva-Leonne
    Rabold, Katrin
    Span, Paul N.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (21) : 6556 - 6556
12345